Login to Your Account

Ablynx, BI Enter Potential $1.8B Deal For 10 Nanobody Targets

By Jim Shrine

Monday, September 10, 2007
Ablynx NV signed its third headline-grabbing deal in 10 months and fifth significant alliance overall, a potential €1.3 billion collaboration that likely will be the last of its kind as the company plans to further assert the strong position of its Nanobody platform going forward. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription